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Abstract: Iron, copper and zinc are transition metals essential for life because they are required in
a multitude of biological processes. Organisms have evolved to acquire metals from nutrition and
to maintain adequate levels of each metal to avoid damaging effects associated with its deficiency,
excess or misplacement. Interestingly, the main components of metal homeostatic pathways are
conserved, with many orthologues of the human metal-related genes having been identified and
characterized in Drosophila melanogaster. Drosophila has gained appreciation as a useful model for
studying human diseases, including those caused by mutations in pathways controlling cellular metal
homeostasis. Flies have many advantages in the laboratory, such as a short life cycle, easy handling
and inexpensive maintenance. Furthermore, they can be raised in a large number. In addition, flies
are greatly appreciated because they offer a considerable number of genetic tools to address some
of the unresolved questions concerning disease pathology, which in turn could contribute to our
understanding of the metal metabolism and homeostasis. This review recapitulates the metabolism
of the principal transition metals, namely iron, zinc and copper, in Drosophila and the utility of this
organism as an experimental model to explore the role of metal dyshomeostasis in different human
diseases. Finally, a summary of the contribution of Drosophila as a model for testing metal toxicity
is provided.
Keywords: Drosophila; metal homeostasis; iron; copper; zinc; frataxin; ATP7; dZip99C;
neurodegeneration; heavy metal toxicity
1. Introduction
Model organisms have been extensively used to unravel basic and conserved biological processes.
The fruit fly, Drosophila melanogaster (hereinafter Drosophila), is one of the most studied eukaryotic
organisms and has made fundamental contributions to different areas of biology. Drosophila has also
gained appreciation as a useful model organism of human diseases. Comparative genomic studies
estimate that up to 75% of the human genes implicated in diseases are conserved in Drosophila [1].
The similarity between human and Drosophila genomes is not limited only to genetic elements, but
also to the relationship between them, with numerous examples of conserved biological mechanisms.
The Drosophila genome is smaller in size and has a smaller number of genes compared to the human
genome, which facilitates genetic studies [2]. Accordingly, many human gene families are composed
of paralogues with redundancy of overlapping functions that correspond to a single gene or a smaller
gene family in Drosophila.
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Flies are greatly appreciated in the laboratory because they are undemanding animals, with a short
generation interval and inexpensive maintenance. Flies can easily be handled, bred and genetically
manipulated in large numbers. Currently, there is a high number of genetic tools available in Drosophila
that allows researchers to address some of the outstanding questions concerning basic processes
underlying human diseases. Furthermore, fly models can be exploited very successfully to discover
the genetic modifiers of disease phenotypes by means of modifier screens [3]. This methodology
is central in identifying novel genes that function in the same disease processes and to progress in
understanding the disease pathology. In turn, this is essential for researching appropriate therapies.
Nowadays, different human diseases have been modeled in Drosophila, which cover a wide range of
physiological alterations, including metabolic dysfunctions and neurodegeneration [4].
Drosophila is also useful for studying potential toxic effects of different compounds, such as
metals [5]. As flies have a short biological life cycle, it is possible to address metal toxicity during
development and adulthood. Survival, neuronal function and behavior assays are easy to perform in
this organism. It is also simple to search for toxicity-mediated mechanisms at the molecular level in
Drosophila [6,7].
This review focuses first on the conserved components that control metal homeostasis in flies.
Following this, it provides instructive examples about what we have learned from Drosophila as a
model for inherited diseases related to metal dysregulation and as a model for testing metal toxicity.
2. Drosophila Genes Involved in Metal Homeostasis
Approximately 25% of proteins require metals to perform their function [8]. Iron (Fe), copper (Cu)
and zinc (Zn) are essential transition metals that organisms assimilate from food. Homeostatic control
of these metals at systemic and cellular levels is vitally fine-tuned to ensure their availability as cellular
nutrients. This fine-tuning also prevents detrimental effects of their deficiency, excess or misplacement.
Proteins for import, transport, storage, excretion and regulation of metals are essential components of
pathways for metal metabolism and homeostasis. Interestingly, the main players of these pathways
are conserved through evolution, with many orthologues of the human metal-related genes having
been identified and characterized in Drosophila. Here, we provide an overview of the uptake, transport
and efflux of Fe, Cu and Zn at the cellular level in flies.
2.1. Iron
Iron (Fe) is required for the survival of almost all organisms, because it plays a crucial role in
many biological processes, such as oxygen transport, cellular respiration, gene regulation and DNA
biosynthesis. Fe participates in such processes through the heme and iron-sulfur cluster (ISC) prosthetic
groups in which Fe shows its ability to exchange electrons with different substrates.
Fe deficit compromises the function of the metabolic pathways in which Fe acts as an important
cofactor. A misplaced and increased level of Fe promotes the formation of reactive oxygen species
(ROS) through the Fenton–Haber–Weiss reaction [9], including the highly reactive hydroxyl radicals.
This results in glutathione consumption, lipid peroxidation and DNA damage, which finally can
compromise cell viability.
Drosophila shares many key genes involved in iron metabolism with mammals (Table 1, Figure 1A).
Malvolio (Mvl), the Drosophila orthologue of the mammalian Divalent metal transporter-1 (DMT1) [10]
is expressed in the fly midgut and has been proposed to function as an importer for dietary iron
in a similar way to its mammalian counterpart [11]. Mammals and insects store iron absorbed in a
bioavailable form of ferrihydrite inside ferritin, a protein formed of heavy and light chain subunits
(coded by the Fer1HCH and Fer2LCH genes respectively in Drosophila). While ferritin is mainly a
cytosolic protein in mammals, it is found in the secretory system (endoplasmic reticulum (ER), Golgi
apparatus and secretory vesicles) in most insects, including Drosophila, and is secreted in the fly
hemolymph in large amounts [12,13]. Transferrin 1 is also an iron-binding protein abundant in the
hemolymph for which multiple functions have been suggested in insects. Nevertheless, it is still
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unsolved whether this protein serves as an iron transport carrier between cells in a similar manner to
the mammalian transferring [14,15]. Iron absorption and metabolism are post-transcriptional processes
regulated by the IRP/IRE system, which is conserved through diverse taxonomic groups [12,16].
When Fe concentration is low, iron regulatory proteins (IRPs) bind to iron-responsive elements (IREs)
on the 5′UTR and 3′UTR mRNAs of their target proteins, which controls translation initiation or mRNA
stability (reviewed in [17]). Two IRP genes (Irp-1A and Irp-1B) have been described in Drosophila and
have both shown aconitase activity, but only Irp-1A functions as an iron regulatory protein [18].
Table 1. Conserved proteins in iron homeostasis.
Human Gene PrimaryMetals Metal-Related Function Drosophila Orthologue References
Divalent Metal Transporter




Ferritin Heavy Chain 1
(FTH1) Fe
A component of ferritin Ferritin 1 heavy chain
homologue (Fer1HCH) [12,15]Iron storage
Ferritin Light Chain (FTL) Fe
A component of ferritin Ferritin 2 light chain
homologue (Fer2LCH) [12,15]Iron storage
Ferritin Mitochondrial
(FTMT) Fe
Iron storage Ferritin 3 heavy chain
homologue (Fer3HCH) [19]Oxidative stress protection
Transferrin (TF) Fe Serum iron binding transport protein Transferrin 1 (Tsf1) [13,14]
Aconitase 1 (ACO1) Fe Iron sensor
Iron regulatory protein 1A
(Irp-1A)
[16,18]
Iron regulatory protein 1B
(Irp-1B)
Mitoferrin 1 (SLC25A37) Fe Mitochondrial iron importer Mitoferrin (mfrn) [19]
Frataxin (FXN) Fe Mitochondrial iron chaperone Frataxin (fh) [20]
Duodenal cytochrome b
(DCYTB, CYBRD1) Fe Ferric-chelate reductase that reduces Fe
3+ to Fe2+
No extended memory (nemy)
[21]
CG1275
Hephaestin (HEPH) Fe Ferroxidase activity oxidizing Fe2+ to Fe3+
Multicopper oxidase-1
(Mco1) [22]
Ceruloplasmin (CP) Fe Ferroxidase activity oxidizing Fe2+ to Fe3+
Multicopper oxidase-3
(MCO3) [23]
Gene symbols for human genes are indicated according to the Human Genome Organization Gene Nomenclature
Committee (HGNC) (Available online: http://www.genenames.org). An alias is indicated in several cases.
Drosophila gene symbols are cited in agreement with the Flybase (Available online: http://flybase.org).
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Figure 1. Main pathways of (A) iron, (B) copper and (C) zinc uptake, storage and export in Drosophila 
melanogaster. TGN, trans-Golgi network; MITO, mitochondria. Question marks represent an unknown 
mechanism. Arrows represent the direction of the metal transport.  
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echanis . rro s represent the direction of the metal transport.
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Genes involved in mitochondrial Fe metabolism are also conserved between flies and humans.
A mitochondrial ferritin has been identified in both organisms (Fer3HCH is the encoding gene in
Drosophila), which has shown an important antioxidant role through the regulation of mitochondrial
Fe availability [19,24]. In fact, the expression of human mitochondrial ferritin in frataxin-deficient
cells protects mitochondria from oxidative stress, which is a situation that provokes mitochondrial
iron overload [25,26]. Similarly, the expression of Fer3HCH in frataxin-deficient flies is able to extend
the mean lifespan of the adult individuals [27]. Bridwell-Rabb et al. propose that frataxin is an iron
chaperone involved in the regulation of ISC biosynthesis [28].
Drosophila also has other orthologues with known iron-related functions in mammals that remain
to be fully elucidated in flies. The Duodenal cytochrome b (Dcytb) is highly expressed in the intestinal
epithelia of mammals and has ferric reductase activity to convert the inorganic dietary iron(III) state,
Fe3+ to the iron(II) state and Fe2+ in the absorption process. In Drosophila, two candidates for this
function have been proposed, which are no extended memory (nemy) and the gene with the annotation
ID of CG1275 [21]. Fe2+ is oxidized to Fe3+ for efflux from intestinal enterocytes into the circulatory
system. Mammalian hephaestin, a transmembrane copper-dependent ferroxidase, plays this role
and mediates iron efflux in cooperation with the basolateral iron transporter, ferroportin 1. Another
copper-dependent oxidase enzyme, ceruloplasmin, participates in the iron transport in plasma in
association with transferrin, which carries iron in the ferric state. It has been suggested that the
multicopper oxidase-1 (Mco1) and the multicopper oxidase-3 (MCO3) may be involved in iron homeostasis
in Drosophila showing hephaestin-like [22] and ceruloplasmin-like [29] functions, respectively. It has
been recently reported that Mco1 orthologues from diverse insect species, including Drosophila, function
as ascorbate oxidases [23], and there is accumulating evidence strongly suggesting that ascorbate within
mammalian systems can regulate cellular iron uptake and metabolism [30]. Thus, iron homeostasis
might also be influenced by the ascorbate redox state in Drosophila.
Finally, there are some mammalian genes participating in Fe metabolism with no known
orthologues in flies, such as those genes encoding the transferrin receptor, the iron export protein,
ferroportin or the iron hormone, hepcidin [31]. It may account for differences in the control of systemic
Fe levels between insects and mammals. However, Drosophila has become a powerful model for
studying human disorders caused by mutations in the main components of cellular Fe homeostasis
pathways. Friedreich’s ataxia is an example of these human conditions, and we report in this review the
contribution of Drosophila as an experimental model in the advancement of knowledge in this disease.
2.2. Copper
Copper (Cu) is a vital co-factor for enzymes involved in a wide range of roles, from oxidative stress
defense (superoxide dismutase (SOD)) to pigmentation (tyrosinase) or energy production (cytochrome
c oxidase). Its usefulness for life comes from its ability to change its oxidation state between the cupric
(Cu(II)) and cuprous (Cu(I)) forms.
In mammals, copper is distributed throughout the organism in two steps [32]. First, Cu is
absorbed in the apical surface of the enterocytes of the small intestine to be exported to the circulation
bound to serum proteins. Following this, Cu is absorbed by the liver, where it is bound to the serum
ceruloplasmin and exported again to the circulation for its use by the peripheral tissues. The liver is
also responsible for the removal of excess Cu, exporting it to the bile for its elimination through the
feces. The main transporter for cellular import of Cu is CTR1 (copper transporter 1), which belongs to
a family of small proteins with three transmembrane domains [33]. Before Cu is transported by CTR1,
Cu(II) is reduced to Cu(I) by reductases in the plasma membrane. The transporter DMT1, which is
involved in iron uptake and reabsorption, could also import Cu, but this possibility requires further
research [34,35].
In Drosophila, copper is transported in a single step from the midgut to all tissues through the
circulation. The multicopper oxidase MCO3 is similar to ceruloplasmin in its ferroxidase activity [29],
but it has not been detected in the hemolymph [36,37]. Some authors suggest that another MCO
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orthologue could still be implicated in Cu homeostasis [38]. As for Cu excretion, it has been observed
that in larvae growing in media with a high Cu concentration, the metal accumulates in the Malpighian
tubules [39]. These organs are located between the midgut and the hindgut, which regulate fluid
and ion balance [40]. Malpighian tubules may absorb excess Cu for its excretion to the hindgut and
elimination through the feces [38]. There are three CTR1 genes in Drosophila (Table 2) with some
differences in their expression patterns [41]. Ctr1A is ubiquitously expressed and is required for
survival [42], suggesting that it is the primary transporter for dietary Cu uptake. Ctr1B expression
in the gut is transcriptionally induced when there is a Cu limitation and repressed in the case of
excess [41]. The expression of Ctr1C seems to take place mainly in the male germline. In Drosophila,
Mvl (the orthologue of the human DMT1) could also contribute to Cu uptake, since a reduction in Mvl
activity causes an increased sensitivity to the Cu limitation in females and S2 cells [43].
Table 2. Conserved proteins in copper homeostasis.
Human Gene Primary Metals Metal-Related Function Drosophila Orthologue References
Solute carrier family 31
member 1 (SLC31A1, CTR1) Cu Copper uptake
Copper transporter 1A (Ctr1A)
Copper transporter 1B (Ctr1B)
Copper transporter 1C (Ctr1C)
[33,41,42]
Copper chaperone for
superoxide dismutase (CCS) Cu Chaperone; copper donor to SOD1
Copper chaperone for
superoxide dismutase (Ccs) [44,45]
Cytochrome c oxidase copper
chaperone (COX17) Cu
Chaperone; copper donor to
COX11 and SCO1 CG9065 [46]
Cytochrome c oxidase copper
chaperone (COX11) Cu
Chaperone; copper transfer to
cytochrome c oxidase CG31648 [46]
Cytochrome c oxidase assembly
protein (SCO1) Cu
Chaperone; copper transfer to
cytochrome c oxidase








ATPase copper transporting α
(ATP7A) Cu
Copper delivery to proteins in the
secretory pathway; copper efflux ATP7 (ATP7) [49–55]
ATPase copper transporting β
(ATP7B) Cu
Copper delivery to proteins in the
secretory pathway; copper efflux ATP7 (ATP7) [49–56]
Gene symbols for human genes are indicated according to the Human Genome Organization Gene Nomenclature
Committee (HGNC) (Available online: http://www.genenames.org). An alias is indicated in several cases.
Drosophila gene symbols are cited in agreement with the Flybase (Available online: http://flybase.org).
Once copper has entered the cell (Figure 1B), it is transported to its target proteins by Cu-specific
chaperones with a high affinity for the metal: CCS, COX17 and ATOX1. The CCS (copper chaperones
for superoxide dismutase) provide Cu for SOD1 [44]. COX17 transfers Cu to the proteins, COX11 and
SCO1, which are located in the inner mitochondrial membrane and deliver the metal to the cytochrome
c oxidase [46]. In mammals, ATOX1 transfers Cu to ATP7A and ATP7B, which are two P-Type ATPase
transporters. ATP7A donates Cu to different enzymes in the secretory pathway [33,49,50]. It is also
required for Cu transport across the blood brain barrier (BBB) and from intestinal enterocytes into
the circulation. ATP7B delivers Cu to ceruloplasmin, and in the case of Cu excess, Cu moves to the
biliary canalicular membrane for its excretion to the bile duct and its elimination through the digestive
tract [49,50,56]. One important characteristic of both transporters is their capacity for trafficking
between the trans-Golgi network and the cell membrane in response to Cu levels.
In Drosophila, orthologues of Atox1, CCS, SCO1 and COX17 have been found, and they are
thought to perform the same roles as in mammals [45,47,48]. However, in the fly, there is only one Cu
transporting P-type ATPase named ATP7, which is expressed in all tissues [51,52]. This transporter is
similar to ATP7A, since it is required for transferring Cu to enzymes in the secretory pathway [52–54]
and from the gut cells to the circulatory system [55]. Moreover, the similarity between ATP7 and
ATP7A has also been observed in functional assays and in the domains that share both proteins [51].
Despite the fact that the efflux activity of ATP7 has been proven [53,55], the translocation of the
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transporter from the trans-Golgi network to the cell membrane in response to the Cu levels has not
been demonstrated yet [38].
Copper levels must be tightly controlled because besides being critical for life, Cu can also be
potentially toxic. It can catalyze the formation of hydroxyl radicals through Fenton reactions and alter
the structure of proteins [57,58]. As a mechanism of scavenging and/or storage of Cu and other metals,
all eukaryotes express a group of proteins known as metallothioneins. These are low weight proteins
with a high content of cysteines that have a great metal binding capacity [59–61]. Metallothioneins are
expressed at a basal level and are strongly induced in response to heavy metal load in order to cope
with their toxicity [59–61]. In mammals, there are four major members of this protein family, namely
MT-I, MT-II, MT-III and MT-IV [62]. In Drosophila, five different metallothioneins have been described,
namely MtnA, MtnB, MtnC, MtnD and MtnE [63,64].
The transcription factor MTF-1 (metal-responsive transcription factor-1) is the main regulator of
the response to heavy metal load, including Cu [61,65,66]. In normal conditions, the majority of MTF-1
is located in the cytoplasm. In conditions of heavy metal load, MTF-1 accumulates in the nucleus and
binds to the metal response elements (MRE) to induce the expression of its target genes, which include
the metallothioneins, both in mammals and Drosophila [66,67]. In Drosophila, MTF-1 is also responsible
for the induction of Ctr1B expression under limited Cu [68] and ATP7 in response to excess Cu [55],
while regulation of CTR1, ATP7A or ATP7B by MTF-1 has not been observed in mammals [38].
2.3. Zinc
Zinc (Zn) is an indispensable and ubiquitous trace element present in many tissues in a wide
range of organisms and is involved in many general cellular functions. It has multitudinous effects on
growth, development, immune system and nervous system function [69]. As a regulatory, catalytic and
structural component, Zn is also needed for proteins involved in DNA repair, transcription, translation
and protein signaling, which requires tight homeostasis. It modulates the stability of cell membranes
by reducing peroxidative damage [70] and provides protection against the disruption of cells [71] by
maintaining the structure and function of the membrane barrier [72]. The majority of Zn is bound with
high affinity to metalloproteins and subsequently is said to be non-bioavailable [73]. Furthermore,
approximately 40% of putative zinc-binding proteins are transcription factors carrying zinc-binding
domains, such as zinc finger motifs, zinc cluster and zinc twist. These enable specific gene regulatory
processes to be activated [73]. Other studies have reported the ability of Zn to act as a neurotransmitter
and a second messenger [74].
The bioavailable Zn concentration is maintained at a nanomolar level through uptake, storage and
secretion [75]. Several studies have indicated that Zn transporters are likely to be the main mechanism
of Zn movement in cells, although diffusion of Zn ions may occur under physiological conditions [76].
In mammals, there are two Zn transporter families. One is composed of solute-linked carrier genes,
namely the SLC39a/Zrt-Irt-like protein family (also known as ZIP proteins), while the other family
includes cation diffusion facilitator genes, the SLC30a family (also known as ZnT proteins) [77].
The ZnT family of transporters specifically promotes the transport of Zn from the cytosol to
extracellular environment or transfers Zn into organelle compartments within the cell, thereby reducing
the concentration of cytosolic zinc. The distribution of ZnTs is widespread, although some are
cell-specific [78]. The ZIP family is comprised of genes that are ubiquitously expressed in all organisms.
This family promotes the transport of Zn from the extracellular environment into the cytoplasm or
from the cellular organelles to the cytoplasm [79]. Thus far, at least fourteen ZIPs and ten ZnTs [77]
have been identified in mammals, while ten ZIPs and seven ZnTs orthologues have been identified in
Drosophila that control the zinc homeostasis (Table 3).
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Table 3. Conserved proteins in zinc homeostasis.
Human Gene Primary Metals Metal-Related Function DrosophilaOrthologue References
SLC30A1 (hZnT1) Zn Exporting cytosolic zinc into the extracellular space dZnT63C
dZnT77C
[80]
SLC30A10 (hZnT10) Mn, Zn Zinc transporter localized to early/recycling endosomes or Golgi [81,82]
SLC30A2 (hZnT2)






SLC30A4 (hZnT4) Zn Maintenance of cytosolic zinc; homeostasis by controlling zinc;translocation to the lysosomes dZnT41F [89]
SLC30A7 (hZnT7) Zn Transports zinc into early secretory pathway and contributing to itshomeostatic control dZnT86D [90,91]
SLC30A9 (hZnT9) Zn No zinc transport functions; acts as nuclear receptor coactivator dZnT49B [92]
SLC39A1 (hZIP1)








SLC39A5 (hZIP5) Zn Zinc importer dZip71B [99,100]
SLC39A6 (hZIP6)
Zn Zinc importer that can be a growth factor-elicited signaling molecule fear of intimacy (foi)
[101,102]
SLC39A10 (hZIP10) [103,104]
SLC39A7 (hZIP7) Zn Zinc importer from endoplasmic reticulum and Golgi apparatus;implicated in the glycemic control in skeletal muscle
Catecholamines up
(catsup) [105,106]
SLC39A9 (hZIP9) Zn Zinc importer localized to the Golgi apparatus and the cell surface;plays a crucial role in B-cell receptor dZip102B [107,108]
SLC39A11 (hZIP11) Zn Not well defined dZip48C [109]
SLC39A13 (hZIP13)
Fe Mobilizes zinc from the lumen of Golgi apparatus and cytoplasmic
vesicles to cytosol and plays a pivotal role in cellular signaling dZip99C
[110]
Zn [111]
Gene symbols for human genes are indicated according to the Human Genome Organization Gene Nomenclature
Committee (HGNC) (Available online: http://www.genenames.org). An alias is also indicated for them. Drosophila
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Catsup (Catecholamines up) and foi (fear of intimacy) are the best characterized Zn transporters in
Drosophila. Catsup is the orthologue of the human hZIP7 gene. The encoded protein is localized in
the ER and Golgi apparatus, playing a more general role in the maintenance of the function of these
organelles. Catsup is present in a punctate pattern in the cell body, axonal and dendritic synapses
of neurons in the central brain in Drosophila. It has been shown to play a role as a negative regulator
of the catecholamine biosynthesis pathway [112], as well as in synaptic transport and release of
dopamine [113]. Catsup mutations produce abnormal accumulation of membrane proteins, such as
Notch receptor, EGFR and APPL in ER and Golgi apparatus [114].
Foi has been suggested to be the orthologue of the human genes hZIP6 and hZIP10, with the
encoded protein located in the basolateral cell membrane. It is implicated in cell migration in the
gonad and trachea morphogenesis [115,116], as well as in embryonic glial cell patterning [117]. Foi
is also necessary for correct specification and consequent differentiation of mesodermal derivatives,
acting as a Zn transporter that regulates Zn cellular homeostasis. Its function can be partially replaced
by other Zn transporters of the same family that have a similar subcellular localization [118].
In Drosophila, dZip42C.1, dZip42C.2 and dZip89B (likely orthologues of hZIP1, hZIP2 and hZIP3)
are the most important transporters for absorption of Zn from the intestinal lumen. All of them are
located in the apical membrane of enterocytes (Figure 1C), and their expression can be affected by
dietary Zn levels (dZip42C.1 and dZip42C.2) [119] or can be independent of Zn content acting as a
constitutive Zn transporter with a lower affinity for this metal (dZip89B) [120].
The Zn release to the hemolymph is mediated through two overlapping Zn exporters, dZnT63C
and dZnT77C (orthologues of hZnT1 and hZnt10) both located in the basolateral membrane of
enterocytes. Ubiquitous RNA interference (RNAi) of dZnT63C results in developmental arrest
at the larval stage, lethality before pupae formation and Zn accumulation under physiological
conditions [121]. Knocking down dZnT77C also produces a greater sensitivity to Zn deficiency [119],
demonstrating that they are key Zn transporters in dietary Zn absorption.
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Intracellular Zn homeostasis and transport is poorly understood in Drosophila. Even so, dZnT86D
is expressed in Malpighian tubules, midgut and other organs. The encoded protein is located in the
Golgi apparatus [122] and has been shown to be important for the control of Zn levels. Ubiquitous
knockdown of dZnT86D causes a severe reduction in Zn level in the whole fly, while gut-specific
knockdown of this gene produces little effect on Zn metabolism, but local alteration of the Zn level
in Golgi apparatus. The larval lethality resulting from ubiquitous silencing of dZnT86D is partially
rescued by expression of hZnT7, which corroborates that it is the orthologue [119].
dZnT33D is another intracellular Zn transporter located in the vesicles, which is the orthologue of
hZnT4. Knocking down this gene ubiquitously induces larval and embryonic lethality, as well as the
expression of MtnB [123]. This indicates that dZnT33D is an important regulator of intracellular Zn
homeostasis, although it does not play a role in the dietary Zn absorption.
Zn reabsorption and excretion are also important processes in the homeostasis of this metal.
dZnT63C is also localized in the basolateral membrane of cells in Malpighian tubules, which suggests
its implication in reabsorption of Zn [121]. dZnT35C and dZip71B are counterparts in Zn excretion.
dZnT35C (orthologue of hZnT3 and hZnT8) is located in the apical membrane in the cells and mutant
flies that has accumulated Zn, which is in support of a role in Zn excretion [124]. dZip71B (orthologue
of hZIP5) is situated in the basolateral membrane, with gene knockdown producing a hypersensitivity
to Zn overload similar to dZnT35C, although this does not happen on normal media. In contrast to
dZnT35C, dZip71B knockdown shows decreased Zn content, implying that dZip71B acts upstream of
dZnT35C to drive Zn excretion in the body [125]. It is suggested that dZip71B functions in transporting
Zn from body into Malpighian tubules and acts together with apically localized dZnT35C to pump Zn
out of the body. Meanwhile, dZnT63C is responsible for zinc reabsorption in Malpighian tubules [125].
Finally, dZnT41F is located intracellularly, and its function is not well defined, although the principal
expression seems to be in the Malpighian tubules. This suggests dZnT63C may be involved in Zn
homeostasis in this organ.
There are other Zn transporters that are predicted to be ZIP and ZnT orthologues in Drosophila,
and phylogenetic analysis indicated that they are related to mammalian genes. dZip48C, dZip102B and
dZnT49B are the orthologues of the human genes hZIP11, hZIP9 and hZnT9 respectively. Furthermore,
dZip88E may be an orthologue of hZIP1 and hZIP2 or hZIP3. Further studies should be carried out to
demonstrate their functions.
No studies have so far addressed the question of why there are so many zinc transporters needed
to regulate Zn homeostasis. One possible explanation is the vast requirement of Zn within the animal’s
body compared to other metals, such as Cu or Fe. Additionally, Zn transporters might participate in the
homeostasis of different metals, because it has been reported that some of them can co-transport Zn and
other metals [126,127]. dZip99C, a member of the ZIP family, was generally believed to import zinc, but
its main function is as a Fe exporter for the secretory pathway [110]. Mutation in the human orthologue
of dZip99C, the hZIP13 gene [110] causes the rare disease spondylocheirodysplasia Ehlers-Danlos
syndrome-like [111,128], which is described in this revision.
3. Drosophila as a Model of Human Inherited Diseases Related to Metal Homeostasis
Drosophila has become a powerful model for studying human disorders caused by mutations
in main components of pathways of cellular metal homeostasis. We find illustrative examples in
Friedreich’s ataxia, an iron-related disorder; in Menkes and Wilson diseases caused by a deficiency
and an excess of copper, respectively; and in spondylocheirodysplasia Ehlers-Danlos syndrome-like
due to mutations in a member of the ZIP family of zinc transporters. In addition, Drosophila has
shown its utility as an experimental model to explore the role of metal dyshomeostasis in different
neurodegenerative diseases.
Int. J. Mol. Sci. 2017, 18, 1456 9 of 29
3.1. Friedreich’s Ataxia
Friedreich’s ataxia (FRDA) is a rare autosomal recessive disease with an estimated prevalence
of 2–4/100,000 in populations of European origin [129]. It is a multisystemic condition affecting the
central and peripheral nervous systems, the heart and other organs. FRDA is caused by a decrease in
frataxin levels due to an intronic GAA triplet repeat expansion within FXN, the gene encoding this
protein [130]. The GAA repeats can form a variety of unusual DNA structures when the GAA expansion
reaches a certain size and have the potential to interfere FXN transcription through heterochromatic
mechanisms [131].
Many studies in model organisms, such as Saccharomyces cerevisiae, Mus musculus, D. melanogaster
and Caenorhabditis elegans, have contributed extensively to our current understanding of the frataxin
function and the physio-pathological consequences of its deficiency [132]. Frataxin is a mitochondrial
nuclear-encoded protein, which has a function that has still not been fully clarified, but it is accepted
that frataxin is required for ISC biosynthesis and for cellular iron homeostasis [28]. Its deficit
provokes dysfunction of ISC-containing enzymes, such as aconitase and some components of the
mitochondrial respiratory chain complexes. Other hallmarks of frataxin deficiency are mitochondrial
iron accumulation coupled to cytosolic iron depletion and increased susceptibility to oxidative
stress [133]. In FRDA patients, excess of iron was first addressed in the myocardium and later
reported in several tissues, such as the spleen, liver and cerebellum [134,135]. In FRDA models,
mitochondrial iron accumulation was first described in yeast [136], before being described in mice [137]
and Drosophila [138]. The role of iron in FRDA pathogenesis has been extensively investigated,
specifically examining whether iron accumulation is either a primary event or an end-stage event, and
focusing on the mechanism underlying iron-mediated toxicity.
The RNAi methodology has been combined with the GAL4/UAS system to successfully knock
down the Drosophila frataxin homolog (fh) [20]. This experimental strategy has provided tissue-specific
and ubiquitous knockdown mutants in which fh suppression is dose dependent [139,140]. Such studies
have indicated that frataxin function is vital during development and that different tissues show
distinct vulnerability to the frataxin deficit. Llorens et al. [140] obtained a knockdown fly line with a
systemic three-fold decrease of frataxin to parallel patient’s conditions more closely. Flies expressing
the 30% residual frataxin have normal embryonic development, but show poor motor coordination
and reduced lifespan in adulthood. These phenotypes are more severe under hyperoxic conditions,
and aconitase activity is strongly reduced in this scenario. These results support the previous proposal
that yeast frataxin can acts as an iron chaperone protecting aconitase against oxidative-mediated
inactivation [141]. In addition, they are in favor of an important role of oxidative stress in the
progression of FRDA. Most studies have suggested that iron accumulation becomes toxic in FRDA by
promoting ROS production through the Fenton reaction [142].
Taking advantage of the valuable genetic screens methodology in Drosophila, Soriano et al.
investigated whether genetic modification of pathways involved in metal homeostasis could improve
the impairment in the motor performance of the FRDA model flies [143]. Knockdown of the iron
homeostasis regulators Irp1-A and Irp-1B and their targets transferrin (Tsf1 and Tsf3) and Mvl was
sufficient to suppress this phenotype by reducing iron overload in the majority of cases [143]. The
function of Tsf3 has not been characterized yet, and its identification as a suppressor for FRDA
phenotypes in flies provides indirect evidence of its involvement in iron metabolism in Drosophila.
Similarly, genetic suppression of the mitochondrial iron importer mitoferrin [19] was able to counteract
physiological and molecular phenotypes of frataxin loss-of-function in flies [27].
A novel ROS independent mechanism that may contribute to neurodegeneration in FRDA
has recently been proposed using mutant flies with a chemically-induced missense mutation in
fh [144]. This severe loss-of-function mutation causes an iron accumulation in adult photoreceptor
neurons when it is selectively expressed in this tissue. No increase in ROS was detected, while
sphingolipid synthesis was upregulated. This in turn activated the 3-phosphoinositide dependent
protein kinase 1 (Pdk1) and myocyte enhancer factor-2 (Mef-2). Interestingly, blocking any step of the
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iron/sphingolipid/Pdk1/Mef-2 pathway suppresses neurodegeneration in mutant flies. Notably, this
pathway is also activated in a mouse model with reduced Fxn levels in nervous systems and in the
cardiac tissue of FRDA patients [145].
Overall, Drosophila models of FRDA support the proposal that iron plays a major role in FRDA
physio-pathology. Although reduction in iron levels by iron chelation has been relatively successful in
clinical trials [146,147], genetic or pharmacological intervention through the sphingolipid/Pdk1/Mef-2
pathway and pathways regulating iron homeostasis are new approaches to be explored in
preclinical studies.
3.2. Menkes and Wilson Syndromes
Menkes and Wilson syndromes are Mendelian disorders of Cu metabolism caused by deficiency
and excess of this metal, respectively [148]. Menkes disease is an X-linked recessive neurodegenerative
disorder with reported incidences of 1 in 300,000 in European countries, 1 in 360,000 in Japan and 1 in
50,000–100,000 in Australia [149]. Patients suffer from skeletal defects, growth failure and progressive
degeneration of the central nervous system and exists considerable variability in the severity of
symptoms. The disease is caused by mutations in the ATP7A gene, which are mostly intragenic
mutations or partial gene deletions [150]. The encoded protein is critical for intestinal absorption of Cu
and its transport across the BBB. Therefore, in Menkes disease, Cu accumulates in the cells of the BBB
and choroid plexus, making the metal unable to reach the neuronal tissue [148,151–153]. The decrease
in Cu levels in the brain results in deficiencies in the activity of Cu-containing enzymes.
Mutation in the copper transporter ATP7B gene causes Wilson disease, an autosomal recessive
condition with an estimated wide prevalence of 1–9 in 100,000. Patients suffer from chronic liver
disease, cirrhosis and several neurological symptoms due to a failure of copper excretion, which leads
to an accumulation of the metal in the liver and brain [154].
As indicated before, Drosophila only has one Cu transporting P-type ATPase (named ATP7),
which has a function that seems to be more closely related to that of ATP7A [51]. To study the role of
ATP7, Norgate and colleagues [52] created a null mutation of the gene using imprecise excision of an
inserted P-element. The mutant larvae were extremely lethargic in comparison with the controls, while
their mouthparts were smaller and reduced in pigmentation. It was observed in first instar larvae
that the upregulation of Ctr1B did not take place, even under Cu-limiting conditions. The authors
suggested that Cu remained trapped in the gut cells and was not transported to the rest of the organism.
As mutant larvae failed to grow and develop to the second instar, it was not possible to conduct any
study in adulthood. To solve this problem, Bahadorani et al. [155] obtained conditional mutants
in which silencing of ATP7 by an RNAi construct was restricted to the gut cells. Tissue-specific
suppression of ATP7 also resulted in pre-adult mortality, but about 50% of the affected individuals
survived to adulthood. Therefore, in this model, it was possible to obtain some adult survivors to
study the effects of the transporter repression in adulthood. These adults showed an average lifespan
that was slightly shorter than controls and a reduction in whole-body Cu content. In addition, they
were sensitized to oxidative stress, probably due to a decrease in the activity of the Cu/Zn superoxide
dismutase [155]. Cu supplementation and MTF-1 overexpression enhanced pupal survival to the
adult stage, and based on this later finding, the authors suggested that induction of MTF-1 expression
could be used as an additional approach for the treatment of Menkes disease. They argued that the
metallothioneins induced by MTF-1 could bind to the excess Cu accumulated in the gut, preventing
its toxicity.
A more recent work has also shown how Drosophila can be a powerful model to study some
details of the different gene mutations responsible for a disease. Mutations in ATB7A and ATP7B are
not only responsible for Menkes and Wilson diseases, but can also be involved in other disorders, such
as distal motor neuropathy [156] and Alzheimer’s disease [157,158]. Mercer et al. [159] introduced
different ATP7A and ATP7B pathogenic mutations into a genomic ATP7 rescue construct. All mutations
abrogated the in vivo function of ATP7 in Drosophila, but the effect produced by each one of them was
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different. The authors also highlighted that this system can be useful to screen for compounds that
would be able to restore the function of the transporters.
3.3. Spondylocheirodysplasia-Ehlers-Danlos Syndrome-Like
Dyshomeostasis of Zn is related to several human disorders, such as diabetes, cancer and
neurodegenerative diseases, and is also related to compromised immunity of the host. Moreover,
mutations in Zn transporters are associated with hereditary human diseases. Examples of these include
the transient neonatal deficiency (hZnT2 mutations), acrodermatitis enteropathica (hZIP4 mutations)
or the spondylocheirodysplasia form of Ehlers-Danlos syndrome (hZIP13 mutations).
The Ehlers-Danlos syndrome (EDS) is a heterogeneous group of inherited disorders of connective
tissue characterized by articular hypermobility, skin hyperelasticity and tissue fragility. It affects skin,
ligaments, joints, bone, blood vessels and internal organs. The natural history and mode of inheritance
differ between the six major types [160]. The spondylocheirodysplasia form of Ehlers-Danlos syndrome
(SCD-EDS) is a very rare condition with a worldwide prevalence of <1 in 1,000,000. It is an autosomal
recessive disease caused by loss-of-function mutations in the hZIP13 gene, which encodes a protein
located in ER/Golgi apparatus [111,128]. The mouse knockout of mZIP13 shows maturation defects
affecting connective tissue development [111]. In these animals, the nuclear translocation of SMAD
transcription factors is impaired, while their phosphorylation is unaffected. In addition, Zn levels
in serum and isolated primary fibroblasts are not altered. At the same time, the Zn level in Golgi
apparatus is upregulated and is downregulated in the nucleus, indicating an accumulation of this metal
in ER/Golgi in the SCD-EDS [111]. It is proposed that zinc accumulation in ER/Golgi can compete
with iron in the secretory pathway affecting the activity of enzymes in this pathway that use Fe as a
cofactor. This is the case of two enzymes, namely lysyl and prolyl hydroxylases, which have a central
role in the biosynthesis of collagens [161]. Mutations in the PLOD1 gene encoding lysyl hydroxylase
(LH1) cause Ehlers-Danlos type VI [162], which shares several clinical signs with SCD-EDS. In contrast
to a zinc excess in SCD-EDS, a later study using human cell cultures has suggested that this disease
may be the result of trapping Zn in vesicles leading to a deficiency of this metal in ER/Golgi rather
than an overload and iron failing to compete with zinc in the importing assay [163].
Clarification of the SCD-EDS molecular pathology comes from analyzing the functions of dZip99C,
the putative fly orthologue of hZIP13. Xiao et al. [110] generated transgenic lines of Drosophila
to study the effects of modulating the expression of dZip99C in specific tissues and in the whole
organism. Surprisingly, the authors found that in Drosophila, dZip99C (a presumed zinc importer) is
considerably involved in dietary Fe absorption. Ubiquitous reduction of dZip99C expression provokes
developmental arrest at the pupal stage, which can be rescued by dietary iron supplementation.
Furthermore, the addition of the iron-specific chelator worsened the phenotype. Tissue-specific
reduction of dZip99C expression in the midgut affects Fe content in whole fly, with a reduction of 50%,
although the Zn level is unaltered. However, Fe levels are not reduced in the cytosol of enterocytes,
which suggests that dZip99C is involved in Fe extrusion from the gut to the body. The authors
investigated the relation of dZip99C and ferritin on iron assimilation, because Drosophila ferritin
transport absorbed dietary iron through the secretory pathway for its systemic use [13]. Thus, dZip99C
is essential for ferric iron loading in the secretory pathway.
The intracellular location of dZip99C was examined in human intestinal Caco2 cells transfected
with a myc-tagged dZip99C construct and in the fly gut. Both cases demonstrated that dZip99C
is located in ER/Golgi in a similar way as its human counterpart. By means of radioactive Fe
transport assay, it was also shown that dZip99C is able to transport Fe in Escherichia coli. The authors
demonstrated that the human gene hZIP13 but not hZIP7, another zinc transporter similar to hZIP13
belonging to the same subfamily of LIV-1 transporters, rescues the developmental defects caused
by knocking down dZip99C in flies. These results show that dZip99C and hZIP13 are orthologues.
The main function of dZip99C and probably for hZIP13 is transporting iron into the secretory pathways.
These results suggest that iron dyshomeostasis instead of zinc is the major cause of SCD-EDS. Mutations
Int. J. Mol. Sci. 2017, 18, 1456 12 of 29
in hZIP13 may compromise iron content into ER/Golgi, affecting the functions of lysyl and prolyl
hydroxylases that are essential for the stability of the collagen triple helix. Further research in human
tissues and other experimental models are needed to confirm iron dyshomeostasis in SCD-EDS.
3.4. Huntington’s Disease
Huntington’s disease (HD) is a neurodegenerative disorder characterized by movement
alterations, psychiatric disturbances and cognitive dysfunction. It is transmitted in an autosomal
dominant manner and its prevalence ranges from 5.96–13.7 cases per 100,000 in North America,
northwestern Europe and Australia [164]. HD is caused by a CAG triplet repeat expansion located in
exon 1 of the HTT gene, which encodes an expanded polyglutamine (polyQ) tract in the huntingtin
(Htt) protein [165].
The mutant Htt-exon1 protein, carrying the polyQ tract, forms aggregates in vitro and
in vivo [166]. Interestingly, it has been shown that the first 171-amino acid fragment of both normal
and mutant proteins interacts with Cu [167] and that the metal favors the aggregation [168]. It is highly
relevant that an increase in Cu levels has been reported in the brains of patients, as well as in mouse
and rat models of HD [167,169,170].
The important role of Cu in HD has been highlighted using a Drosophila model of the disease [171].
Tissue-specific expression of the human Htt exon 1 protein carrying the polyQ expansion has been
analyzed in flies. Expression of this mutated protein in the peripheral nervous system of the fly
provokes alterations in motor coordination. These defects are ameliorated by reducing Cu import via
expression of a Ctr1B RNAi. In contrast, these defects are exacerbated when reducing Cu export by an
ATP7 RNAi. Flies expressing the human mutant Htt in the eyes show photoreceptor degeneration,
which is rescued by Ctr1B RNAi or ATP7 overexpression and enhanced by ATP7 RNAi. Analyzing the
aggregation of Htt-exon1 polyQ protein in the brains of model flies, it is also observed that aggregation
is alleviated by Ctr1B RNAi or ATP7 overexpression and increased by ATP7 RNAi. To further prove
the key role of Cu in HD, Xiao et al. [171] mutated two critical residues potentially implicated in the
binding of Cu to Htt exon1-polyQ. By doing so, the toxicity of the mutant protein was drastically
reduced, and the subsequent phenotypes seemed to be no longer dependent on Cu. Based on these
results, it was shown that HD involves both polyQ toxicity and a Cu-modulating effect, with these two
pathways needing consideration in the treatment of the disease [171].
3.5. Parkinson’s Disease
Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by movement
impairments and mood alterations. It is caused by loss of dopaminergic (DAergic) neurons in
the substantia nigra pars compacta (SNpc) [172], which is mostly due to a sporadic origin with
a contribution of both environmental and genetic factors. There is also a small percentage of familial
cases caused by single gene mutations that can be modeled in organisms like Drosophila. For instance,
mutations in PARK2 are responsible for a form of juvenile Parkinsonism [173]. PARK2 codifies for
PARKIN, an E3 ubiquitin ligase [174,175]. It has been observed that flies lacking the orthologue gene
parkin show mitochondrial abnormalities in muscle and germline tissues in addition to increased
sensitivity to oxidative stress [176–178]. Saini et al. [179] reported interactions of Fe and Cu with
the parkin deficiency in Drosophila. Flies carrying a null mutation (park25/25) of parkin [177] show a
reduction in lifespan, which is rescued using the Cu chelator bathocuproine disulfonate or the Fe
chelator bathophenanthroline sulfonated sodium salt. These flies also show an ROS reduction in their
heads after the chelator treatments. The authors argued that the lifespan extension might be due to
oxidative stress reduction through the sequestration of redox-active Cu and Fe. They further prove the
interaction between parkin and Cu by overexpressing Ctr1B in the fly eye using the GMR promoter.
An increased amount of imported Cu through Ctr1B along with the parkin deficiency was enough to
induce a rough eye phenotype. This phenotype was not present in park25/+ flies overexpressing the Cu
transporter. Using the parkin-deficient flies, it was also shown that other metals could also influence
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the severity of PD. Parkin mutant flies showed an increase in their survival and eclosion frequency
when they were fed on a high-zinc food [180]. These effects could be due to the antioxidant properties
that Zn may exert by being able to protect protein sulfhydryl groups, compete against redox-active
metals or upregulate the expression of metallothioneins [180,181].
Previous data have already shown that several metals could damage dopaminergic neurons
in humans and other model organisms, leading to movement alterations [182–187]. This effect was
also further explored in Drosophila by treating wild type flies (Canton-S) with iron, copper and
manganese [6]. An acute and chronic exposure to high doses of these metals clearly reduced the
lifespan of the flies and the number of neurons of dopaminergic neuron clusters in their brains.
One of the main hallmarks of PD is the presence of Lewy bodies, which are mainly composed
of protein α-synuclein [188]. The toxicity of α-synuclein in dopaminergic neurons may be related
to the formation of protein oligomers. It has been observed that some mutations of the α-synuclein
gene (SNCA), such as A53T and A30P, provoke a faster aggregation in the mutant protein compared
to the wild type one. Moreover, it has been reported that iron binding can increase α-synuclein
aggregation [189] and that the mutant proteins may have a higher ferrireductase activity, converting
Fe3+ to the more reactive Fe2+ [190]. This interaction between α-synuclein and Fe has also been
recently explored in Drosophila. Flies expressing mutant A53T or A30P α-synuclein in dopaminergic
neurons show a higher decline in motor function when treated with Fe compared to flies expressing
the wild type protein in the same Fe conditions [191]. Similarly, Fe only induces a significantly selective
dopaminergic neuron loss in the PPM3 neuron cluster only in the flies expressing the mutant proteins.
3.6. Alzheimer’s Disease
Alzheimer’s disease (AD) is a progressive neurodegenerative condition, which is the main cause
of dementia among aged people [192]. The disorder is characterized by the shrinkage of several regions
in the hippocampus and cortex implicated in memory and cognition. Characteristically, there is an
accumulation of amyloid plaques rich in the β-amyloid (Aβ) peptide and neurofibrillary tangles with
hyperphosphorylated tau in the brain [193]. The toxicity of Aβ aggregates may be due to degradation
of the barrier properties of cellular membranes [194,195], binding to cell receptors [196–199] and the
generation of oxidative stress, since Aβ aggregates can form complexes with redox active metals, such
as Fe and Cu [200,201]. Drosophila has also been used to study the toxicity of the Aβ peptide and its
interaction with metals. Expressing the 42-amino acid isoform of Aβ (Aβ42) in the neurons of flies
resulted in a decrease in lifespan and locomotor performance in comparison with flies expressing the
less toxic 40-amino-acid isoform of Aβ (Aβ40) [202]. The Aβ40 isoform does not contain the final
two hydrophobic residues that make the Aβ42 isoform more prone to aggregation. Expression of
the Aβ42 carrying the Arctic mutation (E22G) [203], which further increases aggregation, produces
even more severe phenotypes. By means of microarray analysis and genetic screen, it was shown
that oxidative stress plays an important role in the toxicity of Aβ42. In fact, the levels of carbonyl
groups in the protein extracts of fly heads increase with the expression of the wild type Aβ42 or the
Arctic Aβ42, which indicates the presence of oxidative damage. In the same study, a strong interaction
between Fe and the toxicity of the Arctic Aβ42 is pointed out. The expression of the heavy or light
subunits of ferritin rescues the phenotypes associated with the Aβ42 toxicity. After this rescue, flies
have an increased survival and motor performance, while carbonyl groups’ content is reduced. It was
suggested that the effect of the ferritin subunits could be due, at least in part, to a reduction in the
hydroxyl radical production by sequestering the Fe ions. In a further study, the same group confirmed
the relevance of Fe in the Aβ toxicity [204]. Flies treated with the Fe-specific chelator YM-F24 had a
reduced toxicity of this peptide, while knocking down the endogenous ferritin worsened it. Moreover,
Fe actively affects the aggregation process of Aβ, delaying the formation of well-ordered aggregates
and possibly promoting its toxicity by this effect. In a recent study, it was shown that Fe affects
the dimerization of Aβ through the interaction with three N-terminal histidines in the peptide [205].
To analyze their position-dependent and position independent effects, histidines were systematically
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substituted by alanine residues in Aβ. It was found that the susceptibility of the flies to oxidative stress
was determined only by the number of histidines.
Most AD clinical forms have sporadic etiology, but there are also some familial forms linked to
mutations in the APP (amyloid precursor protein), PSEN1 (presenilin 1) and PSEN2 (presenilin 2)
genes [206]. Presenilins act as catalytic subunits of the γ-secretase multi-protein complex [207], which
in turn is involved in the cleavage of the amyloid precursor protein. Presenilins also seem to have a role
in Cu and Zn uptake in mammalian systems [208]. This novel role of presenilins has been studied in
Drosophila by tissue-specific knocking down of the single presenilins orthologue (PSN) in the digestive
system [209]. It was observed that the PSN knockdown flies had an increased Cu tolerance due to
a reduced Cu uptake. These flies showed a reduction in total Cu levels and were less sensitive to
excess dietary Cu when overexpressing ATP7. Taking into account that presenilins are involved in the
trafficking and localization of several proteins [210,211], it was suggested that an impaired cellular
localization of Ctr1A and Ctr1B could be responsible for reduced Cu uptake.
4. Drosophila as Model for Testing Metal Toxicity
Heavy metals are natural components of the Earth’s crust. Contamination of heavy metals in the
environment is a major global concern, because of toxicity and threat to human life and ecosystems.
In humans, exposure to heavy metals is mostly occupational [212]. Metal-containing dusts and fumes
are generated along the complete life cycle of metal objects from ore mining through smelting and
final product manufacturing to waste management and recycling. These dusts and fumes are found
in the workplace atmosphere, sometimes at hazardous concentrations. Many metals are xenobiotics
because they used to have a minimal presence (and hence, bioavailability) before emission into the
environment from industry. Furthermore, they either are completely useless and toxic for the human
organism (e.g., mercury, lead or cadmium) or are essential micronutrients, but toxic when given in
excess concentrations (e.g., iron and copper). The toxic effects of heavy metals and their consequences
show a broad spectrum [213]. For example, metals, such as arsenic, cadmium, lead and mercury, cause
many altered conditions including hypophosphatemia, heart disease, liver damage, cancer, central
nervous system injury and sensory disturbances.
Based on the chemical and physical properties of heavy metals, three major molecular mechanisms
of toxicity have been distinguished [214]. The first is production of ROS by auto-oxidation and the
Fenton reaction, which is characteristic for transition metals, such as iron or copper. The second is
blocking of essential functional groups in biomolecules. These reactions have mainly been reported
for non-redox-reactive heavy metals, such as cadmium and mercury. The final mechanism involves
displacement of essential metal ions from biomolecules, which occurs with different types of heavy
metals. As a result of these toxic effects, various cellular metabolic processes are inhibited, which
are detrimental to the cell. Drosophila has also contributed to our understanding of the underlying
mechanisms associated with metal toxicity. Alterations on the cell cycle, circadian rhythms and
enzymatic pathways, DNA repair impairment in addition to genotoxicity are several consequences of
metal toxicity found in flies. Table 4 summarizes the main sources of metal contamination and human
exposition, as well as the clinical symptoms that have been reported in humans and Drosophila findings.
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Table 4. Main sources, routes of human exposure, symptoms and contributions of research in Drosophila.
Metal Natural and Human Sources Main Human Exposure Symptoms Drosophila Findings Reference
Aluminum
Water treatment agents, aerosol,
cosmetics, food additives, beverage
cans, cookware, fireworks,
explosives, rubber manufacturing
Drinking water, food, inhalation, dermal
contact, pharmaceuticals
Mouth ulcers, skin lesions, bone,
lung and brain damage,
neurodegeneration, loss of memory,




impairment, lifespan reduction and daily
rhythm alterations, increase iron
accumulation and ROS production
[215–220]
Arsenic
Arsenic minerals, sedimentary bed
rocks, mining, melting, pesticides,
fertilizers, drugs, soaps
Drinking contaminated water
Abnormal heart beat, damage in
blood vessels, skin lesions, cancer,
neurological problems, high rate
of mortality
Genotoxicity of methylated metabolites,
susceptibility related with genes of the








Contaminated food and drinking water,
inhalation, occupational exposure
Renal dysfunction, bone and lung
damage and kidney disease
Changes in transferase enzymatic
activity, stress response, cell cycle




Burning of petroleum, coil and oil,
pigment oxidants, fertilizers, metal
planting tanneries, sewage,
metallurgy, paper production
Water, occupational exposure Ulcers, fever, renal failure, liverdamage and hemorrhagic diathesis
DNA damage, alterations in pre- and
post-replication mechanism implicated




Pipes, paints, gasoline, cosmetics,
bullets, pesticides, fertilizers,
mining, fossil fuel burning







Alterations in presynaptic calcium
regulation, identification of QTL
associated with behavioral
lead-dependent changes, weak
mutagenic effect, endocrine disruption
[215,227,233–240]
Manganese




Occupational exposure, water and food Manganism, tremors, psychosis,fatigue, irritability
Reduced cell viability, induction of ROS,
decrease in lifespan and
locomotor activity
[6,216,241–246]
Mercury Agriculture, mining, wastewaterdischarges, batteries Contaminated water and marine food
Brain damage, memory problems,
depression, hair loss, fatigue,
tremors, changes in vision
and hearing
Morphometric changes, interference in
cellular signaling pathways and
enzymatic mechanisms, inhibition of
Notch cleavage by γ-secretase
[6,215,243–249]
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5. Conclusions
As a model organism, Drosophila melanogaster has been intensely studied for over a century.
Today, the knowledge related to the biology of the fly and the tools to work with it vastly exceed
those available for many other model organisms. The conservation of many cellular and organismal
processes between humans and flies has also made Drosophila one of the best choices to start studying
many issues relevant for human health. The fly contributes greatly to achieving a better understanding
about metal uptake, distribution, storage or excretion, as well as in establishing the underlying toxicity
mechanisms of metals and their role in the pathophysiology of many human diseases. We have
presented here some illustrative examples of how Drosophila can be used to model and study rare
diseases in which metals are the main players; other highly prevalent neurodegenerative disorders
in which the importance of metals is increasingly being considered; or the toxicity of high levels of
several metals on their own. Nevertheless, there are still many other metal-related disorders and
questions that can be addressed by taking advantage of Drosophila, evidencing the great potential of
this little organism.
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